Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202408565688611Completed
Trial of clonidine and dexmedetomidine in chronic rhinosinusitis (CRS) (2 arms), sponsored by No sponsor. Primary endpoint: Blood loss. Started Jun 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202408565688611.